225 related articles for article (PubMed ID: 21106860)
1. The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).
Qian X; Moss NG; Fellner RC; Taylor-Blake B; Goy MF
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F561-73. PubMed ID: 21106860
[TBL] [Abstract][Full Text] [Related]
2. Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.
Moss NG; Fellner RC; Qian X; Yu SJ; Li Z; Nakazato M; Goy MF
Endocrinology; 2008 Sep; 149(9):4486-98. PubMed ID: 18499760
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.
Moss NG; Riguera DA; Fellner RC; Cazzolla C; Goy MF
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1433-42. PubMed ID: 20861080
[TBL] [Abstract][Full Text] [Related]
4. Dietary salt regulates uroguanylin expression and signaling activity in the kidney, but not in the intestine.
Fellner RC; Moss NG; Goy MF
Physiol Rep; 2016 May; 4(9):. PubMed ID: 27185905
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron.
Carrithers SL; Taylor B; Cai WY; Johnson BR; Ott CE; Greenberg RN; Jackson BA
Regul Pept; 2000 Nov; 95(1-3):65-74. PubMed ID: 11062334
[TBL] [Abstract][Full Text] [Related]
6. Circadian regulation of uroguanylin and guanylin in the rat intestine.
Scheving LA; Jin WH
Am J Physiol; 1999 Dec; 277(6):C1177-83. PubMed ID: 10600769
[TBL] [Abstract][Full Text] [Related]
7. Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.
Qian X; Moss NG; Fellner RC; Goy MF
Endocrinology; 2008 Sep; 149(9):4499-509. PubMed ID: 18499761
[TBL] [Abstract][Full Text] [Related]
8. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
Waldman SA; Tenenbaum R; Foehl HC; Winkle P; Griffin P
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00016. PubMed ID: 31318728
[TBL] [Abstract][Full Text] [Related]
9. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
[TBL] [Abstract][Full Text] [Related]
10. Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides.
London RM; Eber SL; Visweswariah SS; Krause WJ; Forte LR
Am J Physiol; 1999 Jun; 276(6):F882-91. PubMed ID: 10362777
[TBL] [Abstract][Full Text] [Related]
11. Uroguanylin inhibits H-ATPase activity and surface expression in renal distal tubules by a PKG-dependent pathway.
da Silva Lima V; Crajoinas RO; Carraro-Lacroix LR; Godinho AN; Dias JL; Dariolli R; Girardi AC; Fonteles MC; Malnic G; Lessa LM
Am J Physiol Cell Physiol; 2014 Sep; 307(6):C532-41. PubMed ID: 25031022
[TBL] [Abstract][Full Text] [Related]
12. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.
Garin-Laflam MP; Steinbrecher KA; Rudolph JA; Mao J; Cohen MB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G740-9. PubMed ID: 19221018
[TBL] [Abstract][Full Text] [Related]
13. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
14. Cellular effects of guanylin and uroguanylin.
Sindić A; Schlatter E
J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
[TBL] [Abstract][Full Text] [Related]
15. Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent.
Steinbrecher KA; Mann EA; Giannella RA; Cohen MB
Gastroenterology; 2001 Nov; 121(5):1191-202. PubMed ID: 11677212
[TBL] [Abstract][Full Text] [Related]
16. Uroguanylin and guanylate cyclase C in the human pancreas: expression and mutuality of ligand/receptor localization as indicators of intercellular paracrine signaling pathways.
Kulaksiz H; Cetin Y
J Endocrinol; 2001 Jul; 170(1):267-75. PubMed ID: 11431160
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
18. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa.
Sousa CM; Havt A; Santos CF; Arnaud-Batista FJ; Cunha KM; Cerqueira JB; Fonteles MC; Nascimento NR
J Sex Med; 2010 Nov; 7(11):3610-9. PubMed ID: 20102442
[TBL] [Abstract][Full Text] [Related]
19. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Valentino MA; Lin JE; Snook AE; Li P; Kim GW; Marszalowicz G; Magee MS; Hyslop T; Schulz S; Waldman SA
J Clin Invest; 2011 Sep; 121(9):3578-88. PubMed ID: 21865642
[TBL] [Abstract][Full Text] [Related]
20. Purification, cDNA sequence, and tissue distribution of rat uroguanylin.
Li Z; Perkins AG; Peters MF; Campa MJ; Goy MF
Regul Pept; 1997 Jan; 68(1):45-56. PubMed ID: 9094754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
